Infusion reaction to infliximab biosimilar after transitioning from infliximab

Reem Kashlan; Alexis B Lyons; Shanthi Narla; Iltefat H Hamzavi

doi:10.1016/j.jdcr.2020.12.011

Infusion reaction to infliximab biosimilar after transitioning from infliximab

JAAD Case Rep. 2020 Dec 17:8:77-79. doi: 10.1016/j.jdcr.2020.12.011. eCollection 2021 Feb.

Authors

Reem Kashlan¹, Alexis B Lyons², Shanthi Narla², Iltefat H Hamzavi²

Affiliations

¹ Wayne State University School of Medicine, Detroit, Michigan.
² Department of Dermatology, Henry Ford Health System, Detroit, Michigan.

No abstract available

Keywords: ADA, antidrug antibodies; HS, hidradenitis suppurativa; IFX, infliximab; biosimilar; hidradenitis suppurativa; infliximab; infusion reaction.

Publication types

Case Reports